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Abstract  
Introduction: The last case of wild polio virus transmission occurred in Akwa Ibom state in October 2001; however, combination high routine 
immunization coverage with OPV, high quality AFP surveillance, mass immunization campaign in which two doses of potent oral polio vaccine is 
administered to eligible children and mop-up campaigns in areas with identified immunization or surveillance gaps has help the state in maintaining 
a free polio status for over ten years. This study was carried out to describe the characteristics of reported acute flaccid paralysis cases between 
2004 and 2009, and to evaluate the performance of the acute flaccid paralysis surveillance system using indicators recommended by the World 
Health Organization. Methods: A retrospective study was conducted among children, 0-15 years, by the World Health Organization (WHO) and 
Epidemiology unit of State Ministry of Health (SMOH), Uyo. The demographic characteristics and the results of isolation and identification of polio 
and other enteroviruses in stool samples sent to the WHO Polio Laboratory Ibadan for cases was analyzed. Results: A total of 521 cases of AFP 
(270 males and 251 females) aged 0 month to = 15 years were reported by the surveillance system between 2004 and 2009. Those below 5 years 
of age accounted for 82.5% of cases reported and investigated. Of the 521 cases investigated 512 (98.3%) received at least three doses of oral 
polio vaccine, while 9(1.7) never received any oral polio vaccine (zero-dose). In all 5.1% of the isolates were Sabin, 7.9% non polio enterovirus 
(NPEV) and 2.3% were classified by national expert committee as compatible with poliomyelitis. There was consistent and steady increase in three 
critical indicators; Non polio AFP rate in children <15 years from 4.5 to 6.4 per 100 000 population, proportion of AFP cases with 2 stool specimens 
collected within 14 days of onset of paralysis from 57% in 2005 to 91% in 2009 and proportion of Local Government Areas (Districts) meeting both 
core indicators from 23% in 2005 to 87% in 2009. The highest numbers of cases were seen in the months of March, May and September. 
Conclusion: This study showed high levels of surveillance performance with some challenges in reverse the cold chain system, the continuation 
and sustained AFP case detection, prompt investigation and response, improvement in the reserve cold chain system would achieve optimal 
standards recommended by WHO and might provide a good model for the eradication of poliomyelitis.  
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Introduction 
 
Poliomyelitis is a highly infectious disease caused by the Poliovirus in the genus Enterovirus. It affects mainly children under 5 years of age and 
causes paralysis in 1:200-1000 infections [1]. In 1988, the World Health Assembly of the World Health Organization (WHO) resolved to eradicate 
poliomyelitis  by  2000  [2].  In  1996  Nigeria  started  acute  flaccid  paralysis  surveillance  and  in  2000  the  Ministry  of  Health  adopted  a  WHO-
recommended virological classification scheme to replace the clinical classification scheme in use since 1991 [3]. With the new virological criteria, 
final confirmation of Poliomyelitis depends on the isolation of wild poliovirus in the laboratory [4].  
  
Acute Flaccid Paralysis (AFP) is defined as acute or sudden onset of weakness or paralysis of a limb characterized as flaccid (reduced tone) in a 
child < 15 years of age [4]. The surveillance of acute flaccid paralysis is the detection, investigation of flaccid paralysis of new onset in children 
under 15 years or any other suspected poliomyelitis case in a person of any age.  
  
In Akwa Ibom State Polio eradication efforts have been highly successful, with the last case of wild poliovirus reported in October 2001. Since 
then, acute flaccid paralysis (AFP) surveillance has reached high levels of performance, with AFP rates of more than 6.4 per 100 000 children under 
15 years of age being detected. Only AFP cases with wild poliovirus in stool specimens are confirmed as polio, while those with adequate stool 
specimens that are negative for wild poliovirus are considered as non-polio cases. Adequate stool specimens are defined as two stool specimens 
(8–10 g) collected within 2 weeks after onset of illness, with an interval of more than 24 hours between collections, transportation on ice, and 
arrival at the laboratory in good condition (no desiccation, no leakage)[5].  
  
The  WHO  developed  a  set  of  performance  indicators  to  ensure  that  that  AFP  surveillance  is  properly  conducted,  maintained  and  operated 
uniformly., This paper discusses the AFP surveillance findings from 2004 to 2009, evaluates the system and identifies components that requires 
improvement.  
  
  
Methods 
 
In total, there are 324 AFP reporting sites in the 31 LGAs (districts) covering the entire state, with one hundred and eighty four AFP focal persons 
responsible for AFP surveillance at the health facility and community level, while thirty-one disease surveillance and notification officers are at the 
LGA (district) level, four AFP focal persons and one WHO surveillance officer at the state level.  
  
Every case of AFP in those aged 0-15 years has to be notified to LGA DSNO, SMOH and WHO by the AFP focal persons through form AFP F001: 
Immediate AFP case notification form, to the LGA (District) DSNO and AFP C101: Case Investigation form for acute flaccid paralysis to the SMOH 
and WHO with clinical and epidemiological information.  
  
Clinical samples for virological investigation consisting of two stool specimens taken 24-48 hours apart within 14 days of onset of paralysis were 
collected for each case and transported under cold condition in giostyle containing frozen ice packs to the National Polio Laboratory Ibadan. 
Laboratory analysis was done by isolating the virus in RD and L20B cell lines followed by intratypic differentiation using the conventional/ real time 
PCR method.  
  
All  tests  were  carried  out  according  to  the  standard  protocols  recommended  by  WHO  and  cases  classified  based  on  clinical  and  laboratory 
information,  poliomyelitis:  Poliovirus  identified  in  the  stool  specimen;  non  polio:  cases  without  poliovirus  in  stool  specimens  and  no  residual 
paralysis at 60 days; polio compatible: cases not definitely classified as non-polio on the available information. Acute disease with residual paralysis 
after 60 days or death or loss of the subject during follow-up, in which it was not possible to collect at least 2 stool samples within 14 days from 
the  onset  of  paralytic  symptoms;  vaccine-associated  paralytic  poliomyelitis  (VAPP):  paralytic  disease  caused  by  vaccination  with  OPV.  The 
association is thought to be valid if the vaccine is administered on the same subject in a period of time from 4 to 30 days before the onset of 
symptoms.  
  
  
Results 
 
A total of 521 cases of AFP (270 male and 251 female) aged 0 month to ≤ 15 years were reported by the surveillance system between 2004 and 
2009. Those below 5 years of age accounted for the largest proportion (82.5%) of cases reported and investigated (Table 1).  
  
Table 2 illustrates the number and vaccination status of acute flaccid paralysis cases reported to the surveillance system in six years. In 2005, the 
number of AFP cases reported was 58 (11.1%), owing to improved AFP surveillance performance in the state there was remarkable increase in the 
number of cases reported to 70 in 2006, 84 in 2007, 104 in 2008 and 133 (25.6%) in 2009. One indicator of the effectiveness of immunization 
activities is the proportion of children with non-polio acute flaccid paralysis (AFP) who never have received oral poliovirus vaccine (OPV). In total, 
this proportion declined from 3.4% in 2005 to 1.5% in 2009.  
  
Forty one enteroviruses were isolated from the 1042 stool specimens investigated between January 2004 and December 2009, while twenty seven 
were vaccine-related Sabin strains. The National Expert committee classified 12 (2.3%) cases as Polio compatible according to the virological 
flowchart (Table 3).  
  
The WHO defined the target of at least 2 AFP cases per 100 000 in children under 15 years as an indicator for measuring the sensitivity of AFP 
surveillance. This target was consistently achieved from 4.5 in 2004 to 6.4 per 100 000 population in 2009. The proportion of AFP cases with 2 
stool specimen collected within 14 days of onset of paralysis remain consistently above the target of ≥ 80%, except in 2005 where it declined to Page number not for citation purposes  3 
57%, while the proportion of LGAs (districts) meeting two core indicators (Non-Polio AFP rate and Stool adequacy) rose steadily from 23% in 2005 
to 87% in 2009 (Table 4).  
  
  
Discussion 
 
The  primary  objective  of  acute  flaccid  paralysis  surveillance  is  to  detect,  investigate,  report,  disseminate  and  promptly  implement  control 
measures. No wild polio virus has been reported in Akwa Ibom state since October 2001. However, the importation or reintroduction of Poliovirus 
from endemic states remains a threat, this underscore the importance to continue and sustain surveillance for AFP in children younger than 15 
years until global eradication and certification is achieved.  
  
We evaluated the age distribution of AFP cases which is also a risk factor. Four age categories were incorporated in the study, aged zero to one 
year, two to five years, six to ten years and eleven to those less than 15 years. In this study, the proportion of AFP cases 82.5% recorded in 
children aged 5 years and below was lower than the 90% that reported in India [6]. Similarly, another study in Ibadan, southwestern Nigeria also 
reported a lower prevalence (74.3%) among this age group of children [7], while a much lower prevalence of 37% was also reported in Marches 
region, Italy [8],  
  
The isolation of Non Polio Enterovirus (NPEV) is an indicator used to evaluate the integrity and viability of stool specimen dispatched to the 
laboratory for viral isolation. It is expected that at least 10% of stool specimens dispatched to the laboratory should yield NPEV. Findings in this 
study shows that average enteroviruses isolation is 7.6% this finding is close to the findings reported in another study conducted in Bahawalpur, 
Pakistan where NPEV were isolated from 8.5% of AFP cases (9). The frequency of NPEV isolation in our study was however lower than the 34% 
reported in India [10]. Another study also in India had isolated NPEV from 20% of acute poliomyelitis cases [11], while 17.6% was also reported in 
Egypt [12] and 14.6% in Nigeria [13]. The variations observed may be attributed to factors such as differences in the specificity and sensitivity of 
laboratory methods and test kits, stool specimen collection, handling and transportation. The low NPEV isolation in this study may be attributed to 
poor stool collection, poor reverse cold chain and failure to adhere to standard procedures in the collection, handling and shipment of stool 
specimens. The implication of this low NPEV rate is that circulating wild polio viruses may be missed by the surveillance system.  
  
In total, twenty-seven (4.7%) of the 521 acute flaccid paralysis cases yielded vaccine related Sabin strains. Isolation of these strains indicates 
vaccine-associated  paralytic  polio,  a  rare  adverse  event  following  ingestion  of  live  oral  polio  vaccine.  The  mechanism  of  vaccine-association 
paralytic polio is believed to be reversion of the virus from its attenuated form to the virulent form [10]. Reversion is believed to occur in almost all 
vaccine recipients, but rarely results in paralytic diseases, which is more likely seen in immunodeficient children [10].  
  
The 3% of compatible poliomyelitis cases reported during 2004-2009 offered a unique opportunity to document this subgroup of AFP cases, which 
is  becoming  more  important  as  eradication  progresses.  Understanding  the  patterns  of  occurrence  of  compatible  cases  can  help  to  pinpoint 
weaknesses in the AFP surveillance system and indicate what corrective measures should be taken [14]. All the 12 compatible cases were assessed 
14 days after the onset of paralysis and found to be affected by residual weakness. These cases were classified as compatible  because of 
inadequate stool collection, the main factor in which was a long interval between the onset of paralysis and case notification. Additional factors 
contributing to delayed stool collection should be identified and addressed so that this component of the surveillance system can be improved. In 
order to reduce the number of  compatible cases it is necessary to minimize  the  time between the onset of paralysis, case notification and 
investigation. Factors such as weak links at this level may include delays in case presentation to the reporting network, delays between notification 
and the investigation of reported cases [14]. The second most common factor leading to the classification of AFP cases as compatible with 
poliomyelitis was the death of patients for whom two adequate stool specimens had not been obtained [14].  
  
The present study confirms the improvement in AFP surveillance in a poliomyelitis low-risk area of southern Nigeria. According to state data for 
2004-2009 from the same sources, the average rates of non-poliomyelitis AFP rose from 4.5 to 6.5 per 100 000 children, with all cases undergoing 
laboratory diagnosis. This reporting rate was slightly lower than to the national the 7.6 to 7.1 per 100 000 children < 15 years) [15]. Five other 
states achieved AFP surveillance performance indicator rate in 2009 as follows: Bayelsa 8.67, Cross River 5.13, Delta 7.43, Edo 8.35 and Rivers 
3.85  [15].  The  present  results  demonstrate  that  a  significant  proportion  of  AFP  cases  are  reported  in  the  low-risk  areas  in  2004-2009. 
Subsequently, it was confirmed that reporting and laboratory diagnosis improved markedly, reaching approximately 80% for both indicators. Since 
active  surveillance  was  conducted  in  all  prefectures  of  the  thirty–one  districts,  the  observed  changes  were  not  independent  of  the  recent 
improvement in AFP surveillance throughout the districts. Another factor that strongly influences the quality of AFP surveillance is adequacy of 
stool specimens, the frequency of adequate stool specimens ostensibly exceeded 80% district-wide. The WHO AFP surveillance performance 
indicator is 1 Non-Polio AFP case per 100,000 children less than 15 years of age, which is an international standard to assess the sensitivity of a 
national AFP surveillance programme. Non-Polio AFP rate has a directly relationship with population, increase in population figure results in high 
NPAFP rate expected to be recorded to meet the minimum target of NPAFP ≥ 1 per 100,000 population.  
  
Although active surveillance detected a number of cases of clinical poliomyelitis, it was also apparent that as AFP surveillance developed many 
cases were reported late and then subjected to classification by the expert committee. Of the 512 cases of AFP cases in 2004-2009, only 12 were 
finally considered to be genuine compatible cases with poliomyelitis, but there was no geographical clustering and it is hard to imagine that these 
cases could be associated with wild poliovirus. In the state, annual campaigns of supplemental immunization: national immunization days (NIDs) 
and sub-national immunization days (SNIDs) continued nationwide and no outbreak of indigenous wild poliomyelitis was detected anywhere in the 
state after 2001, despite the existence of high-level virus surveillance [16]. Although active surveillance and analysis of clinical poliomyelitis cases 
were shown to be useful, the results clearly indicate that case reporting by AFP surveillance and subsequent laboratory diagnosis were essential to 
evaluate the interruption of wild poliovirus circulation.  
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Vaccine coverage among AFP cases indicates that coverage levels with 3 doses of OPV were uniformly high ranging from 96.6% to 100%. This 
high vaccination coverage perhaps left no room for susceptible children who may help to sustain transmission of poliovirus in the community. It is 
important  to  note  that  lowered  immunization  coverage  may  also  have  serious  consequences  in  countries  that  use  OPV,  as  was  recently 
demonstrated by outbreaks of poliomyelitis due to circulating vaccine derived polioviruses (cVDPV) in Nigeria [17], Hispaniola, (Dominican Republic 
and Haiti) [18], the Philippines [18] and Madagascar [19]. Consequently, high coverage of polio vaccination is not only important in the period until 
the eradication of the wild type polioviruses from human circulation, but for as long as live OPV is in use.  
  
  
Conclusion 
 
In general, the surveillance activity is satisfactory even if in presence of some criticalities in biological samples collection. The continuation of 
surveillance, in addition to the maintenance of current levels of performance, will tend to a further and more detailed sensitization of clinicians and 
other health workers involved, in order to obtain spontaneous and prompt reporting, and to achieve the optimal standards recommended by the 
WHO both in the collection of stool specimens samples and the availability of 60 days follow-up on cases with inadequate stool, Sabin, lost to 
follow-up, with the goal of eradicating polio from country. The state performance indicators are good because the Disease Surveillance and 
Notification Officers (DSNOs) who work at the LGA (district) level are well motivated through monthly stipend of $35 and $134 from WHO and the 
state Government respectively, the WHO state office and state ministry of health (MOH) also undertake data collection, collation and analysis, this 
form the basis with which feedback is provided to the LGA DSNOs and the health facilities. WHO funds monthly review meetings through which 
feedback is provided and intervention planned, this also provides a platform to share best practices. There is also close supportive supervision 
visits to the LGAs and Health Facilities from the state WHO office and officers from the MOH, while best practices from states are shared during 
zonal and country review meetings, the WHO office also publish best practices monthly.  
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Table 1:  Socio-demographic baseline data in an audit of deaths from cervical cancer in a Palliative Care centre, 
Central-East Malawi 
Variables        N  % 
Age ranges 
     
 
> 50 years  25  67.6 
 
30-50 years  10  27 
 
< 30 years  2  5.4 
Educational  
     
 
Never attended school  18  48.6 
 
Primary school  12  25.5 
 
Secondary school  7  18.9 
Residence of participants 
   
 
within Salima District  32  86.4 
 
Neighbour district  3  8.1 
 
From Mozambique  1  2.7 
 
Not documented  1  2.7 
Profession of participants 
   
 
Unemployed  30  81 
 
Small business  2  5.4 
 
 Civil servant  2  5.4 
 
Not documented  2  5.4 
 
Brewer  1  2.7 
Parity 
       
   6-10 pregnancies  20  54 
 
4-6 pregnancies  11  29.7 
 
1-3 pregnancies  4  10.8 
 
> 10 pregnancies  4  10.8 
Total        37 
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Table 2: Characteristics of prescribed medicines in an audit of deaths from cervical cancer in a Palliative Care centre, Central-East 
Malawi  
N  % 
Number of drugs prescribed (n: 37)    
No drug prescribed  4  10.8 
One drug  1  2.7 
Two drug prescribed     5  13.5 
Three drugs prescribed     4  10.8 
Four drugs associated     10  27 
Five drugs  5  13.5 
More than 5 drugs  6  16.2 
Prescriber of drugs 
Clinical officer  14  37.8 
Senior registered nurse     15  55.5 
Registered nurse  5  13.5 
Not sure  3  8.1 
Types of prescribed drugs(37)    
       
Opioids   19  51.3 
Codeine  10  27 
Liquid morphine     9  24.3 
NSAID
a  34  91.8 
Ibuprofen     22  59.4 
Indomethacin     1  2.7 
Diclofenac     5  13.5 
Paracetamol     1  2.7 
Acid acetyl salicylic     1  2.7 
Antibiotics  33  89.1 
Metronidazole     23  62.1 
Cotrimoxazole     5  13.5 
Nystatin  1  2.7 
Erythromycin     1  2.7 
Amoxicillin     2  5.4 
Ciprofloxacin     1  2.7 
Laxatives  3  8.1 
Bisacodyl  1  2.7 
Pawpaw leaves      1  2.7 
Pawpaw seeds     1  2.7 
Steroids  9  24.3 
Kenacort  8  21.6 
Dexamethazone     1  2.7 
Anti-anaemic  
Iron  10  27 
Antiemetic   Metochlopramide  12  32.4 
Others
 b  12  32.4 
aNon steroidien anti-inflammatory drugs; 
bOthers are haloperidol, clorazepate, magnesium  trisilicate, multivitamins, diuretics, amitryptilline, Expectorants and 
disinfectant 
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Table 3: Symptoms prevalence among patients in an audit of deaths from cervical cancer in a Palliative 
Care centre, Central-East Malawi 
   N (37)  % 
Pains  15  55.5 
Haemorrhage 
 
13  35.1 
Watery discharge 
 
7  18.9 
Urinary symptoms 
 
4  10.8 
 Weakness 
 
4  10.8 
Sleeping problems 
 
3  8.1 
Abdominal distension/fullness  2  5.4 
Oedema 
   
2  5.4 
Breathlessness 
 
1  2.7 
Vomiting 
   
1  2.7 
Loose of stools 
 
1  2.7 
Anorexia        1  2.7 
  
 
 
 
 
Table 4: Performance indicators of AFP cases reported to the surveillance system, 2004-2009 
Indicators  Target  2004  2005  2006  2007  2008  2009 
Non polio AFP rate in children <15 years 
≥2  4.5  3.3  3.9  5.1  5.0  6.4 
Proportion of AFP cases with 2 stool specimens collected within 
14 days of onset of paralysis 
80%  97%  57%  87%  92%  95%  91% 
Proportion  of  district  making  monthly  reports  including  zero 
reports 
80%  100%  86%  100%  100
% 
100%  100% 
Proportion  of  AFP  cases  investigated  within  2  days  of 
notification 
80%  100%  97%  100%  100
% 
100%  100% 
Proportion of stool specimens arriving at national level within 3 
days being sent 
80%  100%  100%  100%  100
% 
100%  95% 
Proportion  of  stool  specimens  arriving  at  the  lab  in  good 
condition 
90%  100%  100%  100%  99%  100%  100% 
Proportion of stool specimens from which non polio enterovirus 
was isolated 
10%  2.8%  3.4%  9.0%  12%  8%  5% 
Proportion of stool specimens for which lab results were sent 
within 28 days of receipt at the lab 
80%  100%  100%  100%  100
% 
100%  100% 
Proportion of LGA(District) Meeting both core indicators  80%  100%  23%  58%  74%  81%  87% 
  
  
  
 